AGP Executive Report
Last update: 4 hours agoSolar Technology: China proposed export controls on 12 solar-manufacturing technologies, including licensing limits on some advanced cell processes and bans on select emerging technologies. Finished panels are unaffected; India expects little near-term impact on rooftop prices, but domestic manufacturers could face harder access to equipment and know-how. Implantable Hearing: University Hospitals is testing a fully implanted cochlear device in a Phase 3 trial. Its microphone and battery sit under the skin, eliminating external components if the device proves safe and effective. Surgical Robotics: The FDA authorized Virtuoso Surgical’s robotic system for removing bladder tumors through an endoscope, aiming to preserve tissue for diagnosis. Biomaterials: University of Queensland researchers turned brittle bioplastic into a hydrogel that could support wound recovery, tissue engineering and drug delivery. Resilient Construction: An MIT study found reinforced concrete masonry homes sustained about half the wind damage of wood-frame homes in Hurricane Irma. Medical Manufacturing: India extended its medical-device production incentive scheme to 2035–36 and eased investment and sales requirements to encourage domestic production.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
